As of Tuesday, December 23, Gain Therapeutics, Inc.’s GANX share price has surged by 7.37%, which has investors questioning if this is right time to sell.
Apps that offer creative outlets, particularly those including quick sketching and guided drawing, are becoming a practical ...
The Daily Overview on MSN
How hypergrowth startups are rewriting digital marketing rules
Hypergrowth startups are not just buying ads more efficiently, they are rebuilding the logic of digital marketing from the ...
Seville orange peel extract is one of the most discussed citrus-derived ingredients in metabolism-focused supplements.
Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...
Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...
A rise in reports of psychosis-like symptoms is increasing pressure on companies and policymakers to address the potential ...
Reinforcement Learning, Explainable AI, Computational Psychiatry, Antidepressant Dose Optimization, Major Depressive Disorder, Treatment Personalization, Clinical Decision Support Share and Cite: de ...
Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...
The NY Center for the Prevention of Heart Disease announces expanded services for heart failure patients in Midtown Manhattan ...
This article explores how to evaluate wellness trends responsibly, the role of whole foods and lifestyle habits, and why fundamentals matter more than fleeting popularity.
Pavle Jeremić, Founder and CEO of Aether, is a scientist-entrepreneur focused on turning advanced research into real-world industrial impact. With a background in biomolecular engineering and early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results